HEPATITIS C - 04/09/11
Riassunto |
The transmissibility of viral hepatitis by blood products has been recognized for decades.20 In the latter half of the 20th century, the discovery of the etiologic agents of hepatitis A and hepatitis B led to important medical advances in the diagnosis and treatment of these viral illnesses.22, 77 Nevertheless, it was soon apparent that an unidentified, non-A, non-B (NANB) infectious virus was responsible for most cases of posttransfusion hepatitis.78, 209 Several important studies resulted in information about the epidemiology, transmissibility, and risk factors for the acquisition of this disease. In 1989, Choo et al discovered the elusive causative agent, named hepatitis C virus (HCV), using serum isolated from a patient with NANB hepatitis.39 An assay to detect the circulating antibodies to this virus subsequently was developed,132 paving the way for scientific and clinical studies that have culminated in our current understanding of the virus. This article reviews the prevailing knowledge of the hepatitis C virus, which afflicts millions worldwide in what has been called “the silent epidemic.”
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Address reprint requests to Catherine Petruff Cheney, MD, Division of Gastroenterology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215 |
Vol 14 - N° 3
P. 633-667 - settembre 2000 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
